Core Laboratories Inc.

Energy
Oilfield Services/Equipment
www.corelab.com

Earnings Score
Moat Score
Safety Score

Market Cap $911.21M
PE 35
Debt $142.00M
Cash $21.47M
EV $1.03B
FCF $43.82M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$26.20M
EBIT	$58.96M
ROE	10%
ROA	10%
FCF	$43.82M
Equity	$256.42M
Growth Stability	1
PE	34.78
PEG	0.29
PB	3.55
P/FCF	20.79
P/S	1.74
Price/Cash	0.02
Debt/Equity	0.55
Debt/FCF	3.24
Net Margins	6%
Op. Margins	11%
Earnings CAGR	119%
Sales Growth YoY	7%
Sales Growth QoQ	3%
Sales CAGR	59%
FCF CAGR	81%
Equity CAGR	20%
Earnings Stability	-0.9
Earnings Growth YoY	27%
Earnings Growth QoQ	30%
Earnings CAGR 5Y	119%

Sales CAGR 5Y	59%
FCF CAGR 5Y	81%
Equity CAGR 5Y	20%
Earnings CAGR 3Y	59%
Sales CAGR 3Y	59%
FCF CAGR 3Y	81%
Equity CAGR 3Y	20%
Market Cap	$911.21M
Revenue	$522.82M
Dividend Yield	0%
Payout Ratio	7%
Assets	$600.47M
Total Debt	$142.00M
Cash	$21.47M
Shares Outstanding	46.9M
EV	1.03B
Earnings Score	6%
Moat Score	88%
Safety Score	90%
Final Score	61%
Working Capital	140.29M
Current Ratio	2.48
Shares Growth 3y	1%
Equity Growth QoQ	4%
Equity Growth YoY	12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration, production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

SEC Filings

Direct access to Core Laboratories Inc. (CLB) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30

Sector Comparison

How does Core Laboratories Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Core Laboratories Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 119%

Stability -90%

loading chart...

Core Laboratories Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Core Laboratories Inc. .

Years

Calculation mode

= $78B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$44M	$79M	$143M	$258M	$467M	$843M	$1.5B	$2.8B	$5B	$9B	$16B	$162B
DCF		$72M	$118M	$194M	$319M	$524M	$860M	$1.4B	$2.3B	$3.8B	$6.3B	$63B
Value	$78B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2021	12/2022	12/2023	TTM
Net Margins	4%	4%	7%	6%
ROA	-	-	9%	10%
ROE	-	-	16%	10%

Bad Net Margins (6.08%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	11.68	3.24
Debt over Equity	-	0.93	0.72	0.55
Growth Stability	-	-	-	1

Neutral Debt/FCF ratio (3.24)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (0.55)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	4%	4%	59%
Earnings YoY growth	-	-1%	89%	119%
Equity YoY growth	-	17%	22%	20%
FCF YoY growth	-	-36%	-4%	81%